These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30629316)

  • 1. Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.
    Arcudi S; Ferrari B; Pontiggia S; Tufano A; Artoni A; Mancini I; Peyvandi F
    J Thromb Haemost; 2019 Mar; 17(3):492-498. PubMed ID: 30629316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era.
    Goranta S; Deliwala SS; Haykal T; Bachuwa G
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32532908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
    Tersteeg C; Joly BS; Gils A; Lijnen R; Deckmyn H; Declerck PJ; Plaimauer B; Coppo P; Veyradier A; Maas C; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2017 Dec; 15(12):2432-2442. PubMed ID: 28981198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
    Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
    Underwood MI; Alwan F; Thomas MR; Scully MA; Crawley JTB
    J Thromb Haemost; 2023 Jun; 21(6):1544-1552. PubMed ID: 36813118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.
    Vazquez-Mellado A; Pequeño-Luévano M; Cantu-Rodriguez OG; Villarreal-Martínez L; Jaime-Pérez JC; Gomez-De-Leon A; De La Garza-Salazar F; Gonzalez-Llano O; Colunga-Pedraza P; Sotomayor-Duque G; Gomez-Almaguer D
    Hematology; 2016 Jun; 21(5):311-6. PubMed ID: 26907228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
    Geys L; Roose E; Scroyen I; Rottensteiner H; Tersteeg C; Hoylaerts MF; Vanhoorelbeke K; Lijnen HR
    J Thromb Haemost; 2018 Jan; 16(1):150-163. PubMed ID: 29121438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
    Zhou X; Ye X; Ren Y; Mei C; Ma L; Huang J; Xu W; Wei J; Ye L; Mai W; Qian W; Meng H; Jin J; Tong H
    Front Med; 2016 Dec; 10(4):430-436. PubMed ID: 27878664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga JA; Alberio L
    J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.
    Taylor A; Vendramin C; Oosterholt S; Della Pasqua O; Scully M
    J Thromb Haemost; 2019 Jan; 17(1):88-98. PubMed ID: 30475428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
    Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA
    Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
    Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
    Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
    Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
    Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
    Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.